JNJ logo

JNJ
Johnson & Johnson

48,012
Loading...
Loading...
News
all
press releases
Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings?
JNJ's strong Q3 results, upbeat sales outlook and expanding drug pipeline highlight resilience despite Stelara LOE.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Kenvue Stock Climbs Premarket, Day After Record Slide On UK Lawsuit: Retail Bulls Remain Unshaken
A class-action lawsuit in the UK alleges that the use of J&J's baby talc powder caused cancer and other diseases.
Stocktwits·2d ago
News Placeholder
Halozyme Rallies Almost 40% YTD: How Should You Play the Stock?
HALO's nearly 40% YTD surge is fueled by higher ENHANZE royalties. The Elektrofi deal also positions the company for long-term diversification.
Zacks·2d ago
News Placeholder
J&J Bets on MedTech Growth With Orthopaedics Unit Spin-Off Plan
J&J's surprise plan to spin off its Orthopaedics unit as DePuy Synthes is aimed at sharpening MedTech focus and boosting growth margins.
Zacks·2d ago
News Placeholder
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook
JNJ's Q3 earnings beat and raised 2025 sales outlook could lift healthcare ETFs like IHE, XLV and IYH, heavily weighted toward the drugmaker.
Zacks·3d ago
News Placeholder
TECVAYLI plus DARZALEX FASPRO combination regimen significantly improves progression-free survival and overall survival versus standard of care
TECVAYLI plus DARZALEX FASPRO combination regimen significantly improves progression-free survival and overall survival versus standard of care TECVAYLI plus DARZALEX FASPRO combination regimen...
PR Newswire·3d ago
News Placeholder
Johnson & Johnson Battles New UK Talc Cancer Claims Worth £1B After Massive US Verdict: Report
Meanwhile, analysts raised price targets on the stock following strong Q3 results and the planned orthopedic spin-off.
Stocktwits·3d ago
News Placeholder
Thousands in UK sue Johnson & Johnson over talcum powder cancer risks
The claim involves 3,000 people and focuses on internal memos and scientific reports, seen by the BBC...
BBC News·3d ago
News Placeholder
Markets Mostly Up, Russell 2000 Sets New Closing High
The biggest movers on the day were the Nasdaq, +148 points or +0.66%, and the small-cap Russell 2000 +24 points, +0.97%.
Zacks·3d ago
News Placeholder
Elizabeth Warren: Leftism For Thee But Not Me
Elizabeth Warren: Leftism For Thee But Not Me Authored by Paul Sperry via RealClearInvestigations, When Sen. Elizabeth A. Warren recently traveled to the Big Apple to endorse New York City mayoral...
Zero Hedge·3d ago

Latest JNJ News

View

Advertisement|Remove ads.

Advertisement|Remove ads.